Anterix Inc.
Financial highlights
| Metric | FY 03/31/25 | FY 03/31/24 | FY 03/31/23 | FY 03/31/22 | FY 03/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $6.0M | $4.2M | $1.9M | $1.1M | $921,000 |
| Cost of revenue | — | — | $0 | $5,000 | $1.6M |
| Research and development | $5.7M | $5.7M | $4.4M | $3.6M | $4.3M |
| Operating income | -$11.7M | -$10.1M | -$16.5M | -$36.8M | -$54.8M |
| Pretax income | -$9.5M | -$7.5M | -$15.1M | -$36.5M | -$54.3M |
| Income tax expense | $1.9M | $1.6M | $1.3M | $983,000 | $124,000 |
| Net income | -$11.4M | -$9.1M | -$16.3M | -$37.5M | -$54.4M |
| Balance Sheet | |||||
| Cash and equivalents | $47.4M | $60.6M | $43.2M | $105.6M | $117.5M |
| Current assets | $60.8M | $73.0M | $59.5M | $115.8M | $121.0M |
| Total assets | $333.1M | $324.9M | $278.6M | $278.0M | $253.1M |
| Current liabilities | $27.2M | $18.0M | $31.9M | $9.6M | $8.6M |
| Total liabilities | $176.5M | $163.9M | $98.8M | $91.7M | $40.5M |
| Stockholders' equity | $156.6M | $161.0M | $179.8M | $186.3M | $212.5M |
| Cash Flow Statement | |||||
| Cash from operations | -$29.3M | $42.0M | -$27.2M | $17.9M | -$10.0M |
| Depreciation and amortization | $548,000 | $844,000 | $1.4M | $1.4M | $3.5M |
| Stock-based compensation | $13.5M | $15.5M | $17.9M | $13.6M | $15.9M |
| Capital expenditure | $87,000 | $307,000 | $2.1M | $1.1M | $230,000 |
| Free cash flow | -$29.4M | $41.7M | -$29.4M | $16.9M | -$10.2M |
| Share repurchases | $8.4M | $24.7M | $8.2M | $15.0M | $0 |
| Impairments | $0 | $0 | $0 | $0 | $85,000 |
Shares outstanding 18.7M · Free float 53.1%
Annual filing data through FY ended March 31, 2025; float as of July 4, 2026.